메뉴 건너뛰기




Volumn 69, Issue 3, 2008, Pages 457-463

Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: Outcome and tolerability

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; ESCITALOPRAM; LORAZEPAM; SEROTONIN UPTAKE INHIBITOR;

EID: 42249099805     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0317     Document Type: Article
Times cited : (33)

References (31)
  • 1
    • 3042698646 scopus 로고    scopus 로고
    • Time course of response to antidepressants in late-life major depression: Therapeutic implications
    • Whyte EM, Dew MA, Gildengers A, et al. Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging 2004;21:531-554
    • (2004) Drugs Aging , vol.21 , pp. 531-554
    • Whyte, E.M.1    Dew, M.A.2    Gildengers, A.3
  • 2
    • 0036018502 scopus 로고    scopus 로고
    • Course and rate of antidepressant response in the very old
    • Gildengers AG, Houck PR, Mulsant BH, et al. Course and rate of antidepressant response in the very old. J Affect Disord 2002;69:177-184
    • (2002) J Affect Disord , vol.69 , pp. 177-184
    • Gildengers, A.G.1    Houck, P.R.2    Mulsant, B.H.3
  • 3
    • 34250804814 scopus 로고    scopus 로고
    • Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy
    • Dew MA, Whyte EM, Lenze EJ, et al. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007;164:892-899
    • (2007) Am J Psychiatry , vol.164 , pp. 892-899
    • Dew, M.A.1    Whyte, E.M.2    Lenze, E.J.3
  • 4
    • 13744263880 scopus 로고    scopus 로고
    • Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors
    • Whyte EM, Basinski J, Farhi P, et al. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors. J Clin Psychiatry 2004;65:1634-1641
    • (2004) J Clin Psychiatry , vol.65 , pp. 1634-1641
    • Whyte, E.M.1    Basinski, J.2    Farhi, P.3
  • 5
    • 34250804814 scopus 로고    scopus 로고
    • Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy
    • Dew MA, Whyte EM, Lenze EJ, et al. Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry 2007;164:892-899
    • (2007) Am J Psychiatry , vol.164 , pp. 892-899
    • Dew, M.A.1    Whyte, E.M.2    Lenze, E.J.3
  • 6
    • 18544385073 scopus 로고    scopus 로고
    • Duloxetine for the treatment of major depressive disorder in older patients
    • Nelson JC, Wohlreich MM, Mallinckrodt CH, et al. Duloxetine for the treatment of major depressive disorder in older patients. Am J Geriatr Psychiatry 2005;13:227-235
    • (2005) Am J Geriatr Psychiatry , vol.13 , pp. 227-235
    • Nelson, J.C.1    Wohlreich, M.M.2    Mallinckrodt, C.H.3
  • 7
    • 25844529324 scopus 로고    scopus 로고
    • Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: An open-label study
    • Wohlreich MM, Mallinckrodt CH, Watkin JG, et al. Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study. BMC Geriatr 2004;4:11
    • (2004) BMC Geriatr , vol.4 , pp. 11
    • Wohlreich, M.M.1    Mallinckrodt, C.H.2    Watkin, J.G.3
  • 8
    • 33846807625 scopus 로고    scopus 로고
    • The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients
    • Alexopoulos GS, Katz IR, Reynolds CF, et al. The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001:1-86
    • (2001) Postgrad Med , pp. 1-86
    • Alexopoulos, G.S.1    Katz, I.R.2    Reynolds, C.F.3
  • 11
    • 0016823810 scopus 로고
    • Mini-mental state: A practical method for grading the cognitive state of patients for the clinician
    • Folstein M, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-198
    • (1975) J Psychiat Res , vol.12 , pp. 189-198
    • Folstein, M.1    Folstein, S.2    McHugh, P.R.3
  • 12
    • 0035195760 scopus 로고    scopus 로고
    • Current concepts in mild cognitive impairment
    • Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992
    • (2001) Arch Neurol , vol.58 , pp. 1985-1992
    • Petersen, R.C.1    Doody, R.2    Kurz, A.3
  • 13
    • 51549099524 scopus 로고
    • The assessment of anxiety states by rating
    • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
    • (1959) Br J Med Psychol , vol.32 , pp. 50-55
    • Hamilton, M.1
  • 14
    • 0023244845 scopus 로고
    • The UKU Side Effect Rating Scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
    • Lingjaerde O, Ahlfors UG, Bech P, et al. The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987;334:1-100
    • (1987) Acta Psychiatr Scand Suppl , vol.334 , pp. 1-100
    • Lingjaerde, O.1    Ahlfors, U.G.2    Bech, P.3
  • 15
    • 0026509066 scopus 로고
    • Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale
    • Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41:237-248
    • (1992) Psychiatry Res , vol.41 , pp. 237-248
    • Miller, M.D.1    Paradis, C.F.2    Houck, P.R.3
  • 17
    • 0242469131 scopus 로고    scopus 로고
    • Good treatment outcomes in latelife depression with comorbid anxiety
    • Lenze EJ, Mulsant BH, Dew MA, et al. Good treatment outcomes in latelife depression with comorbid anxiety. J Affect Disord 2003;77:247-254
    • (2003) J Affect Disord , vol.77 , pp. 247-254
    • Lenze, E.J.1    Mulsant, B.H.2    Dew, M.A.3
  • 18
    • 0030045950 scopus 로고    scopus 로고
    • The effect of sequential antidepressant treatment on geriatric depression
    • Flint AJ, Rifat SL. The effect of sequential antidepressant treatment on geriatric depression. J Affect Disord 1996;36:95-105
    • (1996) J Affect Disord , vol.36 , pp. 95-105
    • Flint, A.J.1    Rifat, S.L.2
  • 19
    • 0029786161 scopus 로고    scopus 로고
    • Treatment outcome in recurrent major depression: A post hoc comparison of elderly ("young old") and midlife patients
    • Reynolds CF III, Frank E, Kupfer DJ, et al. Treatment outcome in recurrent major depression: a post hoc comparison of elderly ("young old") and midlife patients. Am J Psychiatry 1996;153:1288-1292
    • (1996) Am J Psychiatry , vol.153 , pp. 1288-1292
    • Reynolds III, C.F.1    Frank, E.2    Kupfer, D.J.3
  • 20
    • 42249092110 scopus 로고    scopus 로고
    • Cymbalta [package insert, Indianapolis, Ind: Eli Lilly; 2006
    • Cymbalta [package insert]. Indianapolis, Ind: Eli Lilly; 2006
  • 21
    • 36249009011 scopus 로고    scopus 로고
    • Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder
    • May 8 [epub ahead of print
    • Saghafi R, Brown C, Butters MA, et al. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder. Int J Geriatr Psychiatry 2007 May 8 [epub ahead of print]
    • (2007) Int J Geriatr Psychiatry
    • Saghafi, R.1    Brown, C.2    Butters, M.A.3
  • 22
    • 34147205286 scopus 로고    scopus 로고
    • Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: Controlled study
    • Andreescu C, Lenze E, Dew M, et al. Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry 2007;190:344-349
    • (2007) Br J Psychiatry , vol.190 , pp. 344-349
    • Andreescu, C.1    Lenze, E.2    Dew, M.3
  • 23
    • 42249112703 scopus 로고    scopus 로고
    • Lexapro [package insert, St. Louis, Mo: Forest Laboratories; 2007
    • Lexapro [package insert]. St. Louis, Mo: Forest Laboratories; 2007
  • 24
    • 0020527558 scopus 로고
    • The Hospital Anxiety and Depression Scale
    • Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-370
    • (1983) Acta Psychiatr Scand , vol.67 , pp. 361-370
    • Zigmond, A.S.1    Snaith, R.P.2
  • 25
    • 0026793525 scopus 로고
    • Time to recovery, chronicity, and levels of psychopathology in major depression: A 5-year prospective follow-up of 431 subjects
    • Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-816
    • (1992) Arch Gen Psychiatry , vol.49 , pp. 809-816
    • Keller, M.B.1    Lavori, P.W.2    Mueller, T.I.3
  • 26
    • 0029786469 scopus 로고    scopus 로고
    • Recovery after 5 years of unremitting major depressive disorder
    • Mueller TI, Keller MB, Leon AC, et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 1996;53:794-799
    • (1996) Arch Gen Psychiatry , vol.53 , pp. 794-799
    • Mueller, T.I.1    Keller, M.B.2    Leon, A.C.3
  • 27
    • 33646336858 scopus 로고    scopus 로고
    • Duloxetine for the treatment of major depressive disorder: A closer look at efficacy and safety data across the approved dose range
    • Mallinckrodt CH, Prakash A, Andorn AC, et al. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range. J Psychiatr Res 2006;40:337-348
    • (2006) J Psychiatr Res , vol.40 , pp. 337-348
    • Mallinckrodt, C.H.1    Prakash, A.2    Andorn, A.C.3
  • 28
    • 1842515339 scopus 로고    scopus 로고
    • Duloxetine in the longterm treatment of major depressive disorder
    • Raskin J, Goldstein DJ, Mallinckrodt CH, et al. Duloxetine in the longterm treatment of major depressive disorder. J Clin Psychiatry 2003;64:1237-1244
    • (2003) J Clin Psychiatry , vol.64 , pp. 1237-1244
    • Raskin, J.1    Goldstein, D.J.2    Mallinckrodt, C.H.3
  • 29
    • 34250832737 scopus 로고    scopus 로고
    • Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial
    • Raskin J, Wiltse CG, Siegal A, et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 2007;164:900-909
    • (2007) Am J Psychiatry , vol.164 , pp. 900-909
    • Raskin, J.1    Wiltse, C.G.2    Siegal, A.3
  • 30
    • 27944488713 scopus 로고    scopus 로고
    • An open-label study of duloxetine for the treatment of major depressive disorder: Comparison of switching versus initiating treatment approaches
    • Wohlreich M, Martinez J, Mallinckrodt C, et al. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. J Clin Psychopharmacol 2005;25:552-560
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 552-560
    • Wohlreich, M.1    Martinez, J.2    Mallinckrodt, C.3
  • 31
    • 0033198690 scopus 로고    scopus 로고
    • Depression without sadness: Alternative presentations of depression in late life
    • Gallo JJ, Rabins PV. Depression without sadness: alternative presentations of depression in late life. Am Fam Physician 1999;60:820-826
    • (1999) Am Fam Physician , vol.60 , pp. 820-826
    • Gallo, J.J.1    Rabins, P.V.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.